ACUTE-GRAFT-VERSUS-HOST DISEASE
Clinical trials for ACUTE-GRAFT-VERSUS-HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new ACUTE-GRAFT-VERSUS-HOST DISEASE trials appear
Sign up with your email to follow new studies for ACUTE-GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial for Kids' transplant complication halted after only 2 participants
Disease control TerminatedThis study aimed to test the safety and effectiveness of a new drug, itacitinib, when given with standard steroids to children who developed a serious complication called acute graft-versus-host disease after a stem cell transplant. The trial was designed for children and teens w…
Matched conditions: ACUTE-GRAFT-VERSUS-HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New approach aims to tame dangerous transplant complication
Disease control TerminatedThis study tested a new combination of three drugs to treat a severe and dangerous complication called acute graft-versus-host disease (GVHD) that can happen after a stem cell or bone marrow transplant. The main goal was to find the lowest possible dose of steroids (corticosteroi…
Matched conditions: ACUTE-GRAFT-VERSUS-HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC